- Smear Microscopy
- Culture Based Tests
- Nucleic Acid Testing
- Mantoux Test (Tuberculin Skin Test)
- Radiography (Chest X-Ray)
- Drug Susceptibility Testing (DST)
- Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)]
Tuberculin Skin Test Market was valued at USD 6.1 billion in 2023 and is poised to grow at a CAGR of 7.1% from 2024 to 2030. The mycobacteria are the primary cause for the infectious tuberculosis disease. The disease attacks the lungs and also other parts of the body like the central nervous system, genitourinary system, and lymphatic system. The disease can be transmitted through air by cough or sneeze and symptoms include chronic cough, night sweats, blood-tinged sputum, and fever. The drivers for the global tuberculin skin test market are rising cases of HIV, growth in pharmaceutical research and development, rise in the geriatric population, rise in cigarette consumption as well as growing awareness of tuberculosis disease. However, the major restraining factors for this market include stringent regulation, multidrug-resistant tuberculosis, and certain technical factors. Moreover, the increased costs of the test may slow down the overall market growth.
Tuberculin Skin Test Market Key Developments:
- In December 2022, Thermo Fisher Scientific Proliferated Global Manufacturing Competencies for Sterile and Biologics in China.
- In December 2022, New research from Roche proposes that glofitamab and Lunsumio may be beneficial as fixed-duration, over-the-counter lymphoma treatments.
- In August 2022, Roche announced a new diagnostic test to assist researchers in better recognizing how the immune system reacts to SARS-CoV-2.
- In May 2022, Hoffmann-La Roche Ltd agreed with the global fund to help low and middle-income countries in reinforcing critical diagnosis infrastructure against infectious disease.
Tuberculin Skin Test Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
7.1%
Largest Market
North America
Fastest Growing Market
North America
Tuberculin Skin Test Market Dynamics
The demand for tuberculosis diagnosis is projected to rise over the coming years as countries become gradually aware of the severity of the disease. Governments have reinforced their policies to minimize the global burden of tuberculosis. The formation of policies to increase tuberculosis diagnosis rates has received prominence in many nations. high incidence of tuberculosis in countries with high burdens and the rising demand for TB testing further increases the need for government policies and regulations to increase tuberculosis diagnosis rates. Additionally, it is expected that, due to growing awareness, sales of TB diagnostics will increase significantly in high-TB-burden countries where the main aim is to reduce tuberculosis cases.
North-America Got Significant Share of
Tuberculin Skin Test Market Regional Analysis
The global tuberculin skin test market in North America will contribute largest market share with growing demand for healthcare, technology usage, innovative tests for diagnosis, treatment, rehabilitation and, overall healthcare improvements. An increase in research and development spending will benefit the market. The Asia Pacific held the second largest market share with increasing cases of the disease in the senior population in Japan.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The tuberculin skin test market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario.
Tuberculin Skin Test Market Segmentation
By Diagnostic Test Type
By End User
- Hospitals
- Clinics
- Laboratories
- Academics and Research
- Others
By Geography
North America
- USA
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Russia
- Rest of Europe
The Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia & New Zealand
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
MEA
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Frequently Asked Questions
Tuberculosis testing market is driven by rise in the prevalence of drug resistant tuberculosis infection.
The leading players in the Tuberculin Skin Test Market include Thermo fisher scientific Inc, Alere Inc, Becton, Dickinson and company, F. Hoffmann-La Roche AG.
North America accounted for the major share of the tuberculosis testing market and the trend is expected to continue during the forecast period.
| 1.Executive Summary |
| 2.Global Tuberculin Skin Test Market Introduction |
| 2.1.Global Tuberculin Skin Test Market - Taxonomy |
| 2.2.Global Tuberculin Skin Test Market - Definitions |
| 2.2.1. By Diagnostic Test Type |
| 2.2.2. By End User |
| 2.2.3. By Region |
| 3.Global Tuberculin Skin Test Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Tuberculin Skin Test Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Tuberculin Skin Test Market By Diagnostic Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Smear Microscopy |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Culture Based Tests |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Nucleic Acid Testing |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Mantoux Test (Tuberculin Skin Test) |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Radiography (Chest X-Ray) |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Drug Susceptibility Testing (DST) |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6.Global Tuberculin Skin Test Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. clinics |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Laboratories |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Academics and Research |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7.Global Tuberculin Skin Test Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Tuberculin Skin Test Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Diagnostic Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Smear Microscopy |
| 8.1.2.Culture Based Tests |
| 8.1.3.Nucleic Acid Testing |
| 8.1.4.Mantoux Test (Tuberculin Skin Test) |
| 8.1.5.Radiography (Chest X-Ray) |
| 8.1.6.Drug Susceptibility Testing (DST) |
| 8.1.7.Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 8.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospitals |
| 8.2.2.clinics |
| 8.2.3.Laboratories |
| 8.2.4.Academics and Research |
| 8.2.5.Others |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Tuberculin Skin Test Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Diagnostic Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Smear Microscopy |
| 9.1.2.Culture Based Tests |
| 9.1.3.Nucleic Acid Testing |
| 9.1.4.Mantoux Test (Tuberculin Skin Test) |
| 9.1.5.Radiography (Chest X-Ray) |
| 9.1.6.Drug Susceptibility Testing (DST) |
| 9.1.7.Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 9.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospitals |
| 9.2.2.clinics |
| 9.2.3.Laboratories |
| 9.2.4.Academics and Research |
| 9.2.5.Others |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Tuberculin Skin Test Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Diagnostic Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Smear Microscopy |
| 10.1.2.Culture Based Tests |
| 10.1.3.Nucleic Acid Testing |
| 10.1.4.Mantoux Test (Tuberculin Skin Test) |
| 10.1.5.Radiography (Chest X-Ray) |
| 10.1.6.Drug Susceptibility Testing (DST) |
| 10.1.7.Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 10.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospitals |
| 10.2.2.clinics |
| 10.2.3.Laboratories |
| 10.2.4.Academics and Research |
| 10.2.5.Others |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Tuberculin Skin Test Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Diagnostic Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Smear Microscopy |
| 11.1.2.Culture Based Tests |
| 11.1.3.Nucleic Acid Testing |
| 11.1.4.Mantoux Test (Tuberculin Skin Test) |
| 11.1.5.Radiography (Chest X-Ray) |
| 11.1.6.Drug Susceptibility Testing (DST) |
| 11.1.7.Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 11.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospitals |
| 11.2.2.clinics |
| 11.2.3.Laboratories |
| 11.2.4.Academics and Research |
| 11.2.5.Others |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Tuberculin Skin Test Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Diagnostic Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Smear Microscopy |
| 12.1.2.Culture Based Tests |
| 12.1.3.Nucleic Acid Testing |
| 12.1.4.Mantoux Test (Tuberculin Skin Test) |
| 12.1.5.Radiography (Chest X-Ray) |
| 12.1.6.Drug Susceptibility Testing (DST) |
| 12.1.7.Other Tests [Serological Tests, Interferon Gamma Release Assay (IGRA)] |
| 12.2. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospitals |
| 12.2.2.clinics |
| 12.2.3.Laboratories |
| 12.2.4.Academics and Research |
| 12.2.5.Others |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Abbott Laboratories, Inc. |
| 13.2.2.Akonni Biosystems, Inc. |
| 13.2.3.Beckton, Dickinson and Company |
| 13.2.4.bioMerieux SA |
| 13.2.5.Cepheid, Inc. |
| 13.2.6.Epistem Holdings plc |
| 13.2.7.Hain Lifescience GmbH |
| 13.2.8.Hologic, Inc. |
| 13.2.9.Qiagen N.V. |
| 13.2.10.Roche Holding AG (F. Hoffmann-La Roche AG) |
| 13.2.11.Sanofi S.A. |
| 13.2.12.Thermo Fisher Scientific, Inc. |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
- Abbott Laboratories, Inc.
- Akonni Biosystems, Inc.
- Beckton, Dickinson and Company
- bioMerieux SA
- Cepheid, Inc.
- Epistem Holdings plc
- Hain Lifescience GmbH
- Hologic, Inc.
- Qiagen N.V.
- Roche Holding AG (F. Hoffmann-La Roche AG)
- Sanofi S.A.
- Thermo Fisher Scientific, Inc.